Literature DB >> 27216550

Association Between Aerobic Exercise and Rosiglitazone Avoided the NAFLD and Liver Inflammation Exacerbated in PPAR-α Knockout Mice.

Helena A P Batatinha1, Edson A Lima1, Alexandre A S Teixeira1, Camila O Souza1, Luana A Biondo1, Loreana S Silveira2, Fabio S Lira2, José C Rosa Neto1.   

Abstract

Nonalcoholic fatty liver disease (NAFLD) is one of the main liver diseases today, and may progress to steatohepatitis, cirrhosis, and hepatocellular carcinoma. Some studies have shown the beneficial effects of aerobic exercise on reversing NAFLD. To verify whether chronic aerobic exercise improves the insulin resistance, liver inflammation, and steatohepatitis caused by a high fat diet (HF) and whether PPARα is involved in these actions. C57BL6 wild type (WT) and PPAR-α knockout (KO) mice were fed with a standard diet (SD) or HF during 12 weeks; the HF mice were trained on a treadmill during the last 8 weeks. Serum glucose and insulin tolerances, serum levels of aspartate aminotransferase, hepatic content of triacylglycerol, cytokines, gene expression, and protein expression were evaluated in all animals. Chronic exposure to HF diet increased triacylglycerol accumulation in the liver, leading to NAFLD, increased aminotransferase in the serum, increased peripheral insulin resistance, and higher adiposity index. Exercise reduced all these parameters in both animal genotypes. The liver lipid accumulation was not associated with inflammation; trained KO mice, however, presented a huge inflammatory response that was probably caused by a decrease in PPAR-γ expression. We conclude that exercise improved the damage caused by a HF independently of PPARα, apparently by a peripheral fatty acid oxidation in the skeletal muscle. We also found that the absence of PPARα together with exercise leads to a decrease in PPAR-γ and a huge inflammatory response. J. Cell. Physiol. 232: 1008-1019, 2017.
© 2016 Wiley Periodicals, Inc. © 2016 Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27216550     DOI: 10.1002/jcp.25440

Source DB:  PubMed          Journal:  J Cell Physiol        ISSN: 0021-9541            Impact factor:   6.384


  8 in total

1.  The effects of S-nitrosylation-induced PPARγ/SFRP5 pathway inhibition on the conversion of non-alcoholic fatty liver to non-alcoholic steatohepatitis.

Authors:  Hongyun Wang; Fengxia Li; Jing Feng; Junping Wang; Xiaobing Liu
Journal:  Ann Transl Med       Date:  2021-04

2.  A Biomedical Investigation of the Hepatoprotective Effect of Radix salviae miltiorrhizae and Network Pharmacology-Based Prediction of the Active Compounds and Molecular Targets.

Authors:  Ming Hong; Sha Li; Ning Wang; Hor-Yue Tan; Fan Cheung; Yibin Feng
Journal:  Int J Mol Sci       Date:  2017-03-13       Impact factor: 5.923

3.  Metabolic Reprogramming by 3-Iodothyronamine (T1AM): A New Perspective to Reverse Obesity through Co-Regulation of Sirtuin 4 and 6 Expression.

Authors:  Fariba M Assadi-Porter; Hannah Reiland; Martina Sabatini; Leonardo Lorenzini; Vittoria Carnicelli; Micheal Rogowski; Ebru S Selen Alpergin; Marco Tonelli; Sandra Ghelardoni; Alessandro Saba; Riccardo Zucchi; Grazia Chiellini
Journal:  Int J Mol Sci       Date:  2018-05-22       Impact factor: 5.923

4.  Effects of Long-Term DHA Supplementation and Physical Exercise on Non-Alcoholic Fatty Liver Development in Obese Aged Female Mice.

Authors:  Jinchunzi Yang; Neira Sáinz; Elisa Félix-Soriano; Eva Gil-Iturbe; Rosa Castilla-Madrigal; Marta Fernández-Galilea; J Alfredo Martínez; María J Moreno-Aliaga
Journal:  Nutrients       Date:  2021-02-03       Impact factor: 5.717

5.  Exploring Anti-Nonalcoholic Fatty Liver Disease Mechanism of Gardeniae Fructus by Network Pharmacology, Molecular Docking, and Experiment Validation.

Authors:  Zhongyan Tang; Lin Li; Zhengxiang Xia
Journal:  ACS Omega       Date:  2022-07-12

Review 6.  PPARα: A potential therapeutic target of cholestasis.

Authors:  Xiaoyin Ye; Tong Zhang; Han Han
Journal:  Front Pharmacol       Date:  2022-07-18       Impact factor: 5.988

7.  Gynostemma pentaphyllum Attenuates the Progression of Nonalcoholic Fatty Liver Disease in Mice: A Biomedical Investigation Integrated with In Silico Assay.

Authors:  Ming Hong; Zhe Cai; Lei Song; Yongqiang Liu; Qi Wang; Xiangfei Feng
Journal:  Evid Based Complement Alternat Med       Date:  2018-03-21       Impact factor: 2.629

8.  Alterations in the innate immune system due to exhausting exercise in intensively trained rats.

Authors:  Sheila Estruel-Amades; Mariona Camps-Bossacoma; Malén Massot-Cladera; Francisco J Pérez-Cano; Margarida Castell
Journal:  Sci Rep       Date:  2020-01-22       Impact factor: 4.379

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.